Titan Medical was officially delisted from the Nasdaq in March 2023 because its share price stayed below $1.00 for too long.
The original Titan Medical focused on the . However, after struggling with funding and failing to find a buyer, the company halted development of that robot in 2023. By late 2024, Titan Medical entered into a reverse take-over (RTO) agreement with Conavi Medical Inc. .
If you wanted , this is no longer the right play. If you like Cardiovascular Imaging , the new Conavi entity might interest you. Market Status
The "Titan" you see today is likely the "Resulting Issuer" known as Conavi Medical Corp (CNVI.V), which focuses on image-guided technologies for minimally invasive heart procedures rather than surgical robotics. 2. Listing Status and Liquidity
